Related Experiment Video
Updated: Aug 6, 2025

Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Obesity-associated cancer risk reduction after metabolic surgery: insights from the SPLENDID study and the path
Rickesha Wilson1, Ali Aminian1
1Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, Ohio.
Abstract:
Obesity incidence continues to rise globally along with obesity-associated conditions, which heavily burden individuals' quality of life and healthcare systems. Evidence regarding the power of metabolic and bariatric surgery to treat obesity has, fortunately, brought to light how substantial and sustained weight loss can mitigate adverse clinical outcomes of obesity and metabolic disease. Obesity-associated cancer has been an important focus of studies in recent decades to further elucidate what impact metabolic surgery could have on incidence of cancer and cancer-related mortality. The SPLENDID (Surgical Procedures and Long-term Effectiveness in Neoplastic Disease Incidence and Death) study is one of the recent large cohort studies that highlights the power of substantial weight loss and the long-term benefits to patients with obesity in preventing cancer. This review of SPLENDID aims to highlight both consistency of results with prior studies and new findings unexplored previously.
Related Concept Videos
Cancer Prevention
Some...
Obesity
Cancer Survival Analysis
Psychoneuroimmunology: Diabetes and Cancer
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

